A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(12 sites)

United States

Santa Monica Clinical Trials, Santa Monica, California

PharmDev Research Institute, LLC, Miami, Florida

Central Florida Pediatric Sleep Disorders Institute (Florida Pediatric Research Institute, LLC), Winter Park, Florida

NeuroTrials Research Inc., Atlanta, Georgia

Phillip Nowlin, Stockbridge, Georgia

St. Luke's Hospital, Sleep Medicine and Research Center, Chesterfield, Missouri

Clinical Research of Gastonia, Gastonia, North Carolina

Stern Research Partners, LLC, Huntersville, North Carolina

David Kudrow, MD, Morrisville, North Carolina

Respiratory Specialists, Wyomissing, Pennsylvania

K2 Medical Research, Nashville, Tennessee

West Virginia University, Morgantown, West Virginia